Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BBNXBBNX
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BETA BIONICS INC

GOLDMAN SACHS GROUP INC holds 537,105 shares of BBNX (BETA BIONICS INC), worth $8.4M as of 2026-Q2. The position was increased (+342.7% shares). BBNX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$8.4M

Current Shares

537,105

Total Value Change

+$7.7M

Total Shares Change

+478,683

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
537,105
+342.7%
$8.4M0.0%$15.67
44
2026-Q1
Decreased
121,334
-70.1%
$1.2M0.0%$11.57
0
2025-Q4
Increased
405,408
+1.5%
$12.4M0.0%$31.97
28
2025-Q3
Increased
399,253
+28.4%
$7.9M0.0%$19.85
34
2025-Q2
Increased
311,001
+432.3%
$4.5M0.0%$15.07
43
2025-Q1
New
58,422
-
$715,0850.0%$11.71
34

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used